Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study-Reference-Cited by-同舟云学术

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

Published:2011-07 Issue:7 Volume:22 Page:1535-1546
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bokemeyer C.,Bondarenko I.,Hartmann J.T.,de Braud F.,Schuch G.,Zubel A.,Celik I.,Schlichting M.,Koralewski P.

Funder

Merck KGaA

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/7/1535/13785956/mdq632.pdf

Reference33 articles.

1. E Van Cutsem I Lang G Folprecht. Cetuximab plus FOLFIRI in the treatment of metastatic colorectal cancer (mCRC): the influence of KRAS and BRAF biomarkers on outcome: updated data from the CRYSTAL trialIn American Society of Clinical Oncology 2010 Gastrointestinal Cancers Symposium (Abstr 281). Orlando, FL 2010

2. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial;Pirker;Lancet,2009

3. Platinum-based chemotherapy plus cetuximab in head and neck cancer;Vermorken;N Engl J Med,2008

4. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival;Bonner;Lancet Oncol,2009

5. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer;Bokemeyer;J Clin Oncol,2009

Cited by 650 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer;Nature Communications;2024-02-01

2. Dermatologic toxicities in epidermal growth factor receptor: a comprehensive pharmacovigilance study from 2013 to 2023;Frontiers in Medicine;2024-01-24

3. Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1;International Journal of Clinical Oncology;2023-11-29

4. Case report outcome of cetuximab treatment in a metastatic colorectal cancer patient with novel KRAS P34R;Anti-Cancer Drugs;2023-11-29

5. Current treatment options for BRAF V600E mutant metastatic colorectal cancer;Onkologie;2023-11-29